This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

AlerisLife Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Jeff Leer

İcra Kurulu Başkanı

US$1.1m

Toplam tazminat

CEO maaş yüzdesi	28.1%
CEO görev süresi	less than a year
CEO sahipliği	1.3%
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	15.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Jeff Leer'un ücretlendirmesi AlerisLife'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2022	n/a	n/a	-US$38m
Jun 30 2022	n/a	n/a	-US$39m
Mar 31 2022	n/a	n/a	-US$43m
Dec 31 2021	US$1m	US$300k	-US$30m
Sep 30 2021	n/a	n/a	-US$16m
Jun 30 2021	n/a	n/a	-US$2m
Mar 31 2021	n/a	n/a	US$13m
Dec 31 2020	US$677k	US$279k	-US$8m
Sep 30 2020	n/a	n/a	US$6m
Jun 30 2020	n/a	n/a	-US$5m
Mar 31 2020	n/a	n/a	-US$4m
Dec 31 2019	US$487k	US$145k	-US$20m

Tazminat ve Piyasa: Jeff 'nin toplam tazminatı ($USD 1.07M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 474.54K ).

Tazminat ve Kazançlar: Jeff şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Jeff Leer (42 yo)

less than a year

Görev süresi

US$1,066,500

Tazminat

Mr. Jeffrey C. Leer, also known as Jeff, is President and Chief Executive Officer of AlerisLife Inc. since 2022. He served as Executive Vice President at AlerisLife Inc. since June 1, 2019 and served as Ch...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Adam Portnoy	Chairman & MD	5yrs	US$76.88k	0.17% € 70.6k
Jeffrey Leer	President & CEO	less than a year	US$1.07m	1.3% € 533.6k
Jennifer Clark	MD, Secretary & Director	no data	US$76.88k	0.37% € 150.9k
Heather Pereira	Senior VP	less than a year	Veri yok	0.14% € 57.2k
Philip Benjamson	Senior VP & COO	less than a year	Veri yok	0.14% € 57.2k
Stephen Geiger	VP & Chief Accounting Officer	less than a year	Veri yok	0.21% € 84.6k
James Kotarski	VP & Chief Information Officer	no data	Veri yok	Veri yok
Timothy Bonang	Vice President of Investor Relations	no data	Veri yok	Veri yok
Vijay Moses	Senior VP & General Counsel	1.2yrs	Veri yok	Veri yok
Susan Dooley	Vice President of Marketing	1.2yrs	Veri yok	Veri yok
Michael Lopez	Senior VP & Chief People Officer	1.2yrs	Veri yok	Veri yok
Priti Jindal	Chief Medical Officer	no data	Veri yok	Veri yok

1.0yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: FSQA 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Adam Portnoy	Chairman & MD	5yrs	US$76.88k	0.17% € 70.6k
Jennifer Clark	MD, Secretary & Director	3.1yrs	US$76.88k	0.37% € 150.9k
Gerard Martin	Independent Director	22.2yrs	US$151.88k	0.18% € 74.4k
Bruce Gans	Independent Director	22.2yrs	US$174.38k	0.13% € 53.2k
Donna Fraiche	Lead Independent Director	12.3yrs	US$184.38k	0.12% € 49.4k
Barbara Gilmore	Independent Director	19.2yrs	US$176.88k	0.13% € 54.3k

15.8yrs

Ortalama Görev Süresi

71yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: FSQA 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 15.8 yıldır).

This company listing is no longer active

AlerisLife Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Chairman & MD recently bought €27m worth of stock

Insufficient new directors

Alerislife Inc. Appoints Philip Benjamson as Senior Vice President and Chief Operating Officer

AlerisLife Inc. Announces Chief Financial Officer Changes

AlerisLife Inc. Announces Management Changes

AlerisLife Inc., Annual General Meeting, Jun 07, 2022

Recent updates

Chairman & MD recently bought €27m worth of stock

Insufficient new directors

ABP Acquisition LLC entered into an agreement to acquire the remaining 93.7% stake in AlerisLife Inc. (NasdaqCM:ALR) from Diversified Healthcare Trust (NasdaqGS:DHC) and others for $41.2 million.

AlerisLife Inc. Receives a Notification Letter from Nasdaq Regarding Minimum Bid Price

No longer forecast to breakeven

Third quarter 2022 earnings released: US$0.27 loss per share (vs US$0.32 loss in 3Q 2021)

Alerislife Inc. Appoints Philip Benjamson as Senior Vice President and Chief Operating Officer

AlerisLife Inc. to Report Q3, 2022 Results on Nov 02, 2022

AlerisLife Inc. Announces Chief Financial Officer Changes

No longer forecast to breakeven

Second quarter 2022 earnings released: US$0.28 loss per share (vs US$0.39 loss in 2Q 2021)

AlerisLife Inc. to Report Q2, 2022 Results on Aug 03, 2022

First quarter 2022 earnings released: US$0.31 loss per share (vs US$0.10 profit in 1Q 2021)

AlerisLife Inc. Announces Management Changes

Forecast breakeven date pushed back to 2024

Forecast breakeven date pushed back to 2024

AlerisLife Inc., Annual General Meeting, Jun 07, 2022

AlerisLife Inc. to Report Q1, 2022 Results on May 03, 2022

Insider recently bought €91k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

AlerisLife Inc. to Report Q4, 2021 Results on Feb 23, 2022

Third quarter 2021 earnings released: US$0.32 loss per share (vs US$0.12 profit in 3Q 2020)

Forecast to breakeven in 2022

Second quarter 2021 earnings released: US$0.39 loss per share (vs US$0.095 profit in 2Q 2020)

Forecast breakeven pushed back to 2022

Five Star Senior Living Inc.(NasdaqCM:FVE) dropped from Russell 3000E Value Index

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS US$0.10 (vs US$0.55 loss in 1Q 2020)

New 90-day low: €5.20

Chief Accounting Officer has left the company

Full year 2020 earnings released: US$0.24 loss per share (vs US$3.99 loss in FY 2019)

Investor sentiment improved over the past week

New 90-day high: €6.75

Five Star Senior Living Inc. Partners with CVS to Administer Vaccines to Shop Community Residents and Staff, Which Commenced in December 2020

Five Star Senior Living Inc. to Report Q4, 2020 Results on Feb 24, 2021

Investor sentiment improved over the past week

New 90-day high: €6.05

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: €4.60

Market bids up stock over the past week

Third quarter 2020 earnings released: EPS US$0.12

New 90-day low: €3.74

Five Star Senior Living Inc. to Report Q3, 2020 Results on Nov 05, 2020

New 90-day high - €3.90

First half earnings released

Five Star Senior Living Inc. to Report Q2, 2020 Results on Aug 06, 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş